Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jan 14;13:367–377. doi: 10.2147/CMAR.S277399

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 Cheng et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

CYP1B1 reverses the regulation of cisplatin induced apoptosis by UCA1 or miR-513a-3p in human gastric cancer cells. (A–B) CYP1B1 overexpression decreased cisplatin induced apoptosis in UCA1 knockdown NCI-N87 cells using detection of flow cytometer (A), and apoptotic cells were statistically compared (B); (C and D) CYP1B1 knockdown increased cisplatin induced apoptosis in miR-513a-3p knockdown NCI-N87 cells using detection of flow cytometer (C), and apoptotic cells were statistically compared (D). Each experiment was repeated three times independently. The rate of apoptosis cells was shown as mean ±SD, *p<0.001 vs si-UCA1 group, **p<0.001 vs inhibitor group, and the p-value was calculated by Student’s t-test.